Authors:
Abrams, D
Allan, D
Antunes, F
Breckenridge, A
Bruun, J
Cameron, W
Carbon, C
Chalmers, I
Chang, H
Chodakewitz, J
Clendenin, N
Clumeck, N
Collier, A
Collins, G
Cooper, E
Cooper, D
Danner, S
D'Aquila, R
DeGruttola, V
DeMasi, R
Dee, L
Deyton, L
Dixon, D
Farthing, C
Feinberg, J
Fischl, M
Flepp, M
Gartland, M
Gatell, J
Gazzard, B
Goebel, F
Gotzsche, P
Gringeri, A
Hall, D
Hamilton, J
Hammer, S
Hartigan, P
Heath-Chiozzi, M
Henry, K
Hill, A
Hirschel, B
Ioannidis, J
Kahn, J
Katlama, C
Katzenstein, D
Killen, J
King, E
de Loes, SK
Kravcik, S
Lange, J
Leavitt, R
Leonard, J
Maeland, A
Mannucci, P
Mathiesen, L
McDade, H
Meibohn, A
Melander, H
Merigan, T
Mulder, J
Myers, M
Neaton, J
Nessling, M
Perrin, L
Pettinelli, C
Phair, J
Phillips, A
Pinching, A
Poppa, A
Power, L
Reiss, P
Richman, D
Rooney, J
Rousseau, F
Rutherford, G
Salgo, M
Sandstrom, E
Saravolatz, L
Savidge, G
Schnittman, S
Schooley, R
Seligmann, M
Simberkoff, M
Skowron, G
Slade, P
Smith, D
Smith, RP
Soriano, V
Stanley, K
Stingl, G
Stoffels, P
Struthers, L
Tierney, C
Thompson, M
Van der Broeck, R
Van Leeuven, R
Van Weverling, G
Veenstra, J
Vella, S
Volberding, P
Weber, J
Winslow, D
Yeni, P
Yeo, J
Dormont, J
Sande, M
Weller, I
Babiker, A
Collins, R
Darbyshire, J
Duncan, W
Foulkes, M
Hughes, M
Peto, R
Peto, T
Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025